|
1
|
Duband JL, Gimona M, Scatena M, Sartore S
and Small JV: Calponin and SM 22 as differentiation markers of
smooth muscle: Spatiotemporal distribution during avian embryonic
development. Differentiation. 55:1–11. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Owens GK, Kumar MS and Wamhoff BR:
Molecular regulation of vascular smooth muscle cell differentiation
in development and disease. Physiol Rev. 84:767–801. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davis-Dusenbery BN, Wu C, Hata A and Sessa
WC: Micromanaging vascular smooth muscle cell differentiation and
phenotypic modulation. Arterioscler Thromb Vasc Biol. 31:2370–2377.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim VN: MicroRNA biogenesis: Coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Niwa R and Slack FJ: The evolution of
animal microRNA function. Curr Opin Genet Dev. 17:145–150. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hammond SM: RNAi, microRNAs, and human
disease. Cancer Chemother Pharmacol. 58(Suppl 1): s63–s68. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davis BN, Hilyard AC, Nguyen PH, Lagna G
and Hata A: Induction of microRNA-221 by platelet-derived growth
factor signaling is critical for modulation of vascular smooth
muscle phenotype. J Biol Chem. 284:3728–3738. 2009. View Article : Google Scholar :
|
|
9
|
Wang YS, Wang HY, Liao YC, Tsai PC, Chen
KC, Cheng HY, Lin RT and Juo SH: MicroRNA-195 regulates vascular
smooth muscle cell phenotype and prevents neointimal formation.
Cardiovasc Res. 95:517–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li P, Zhu N, Yi B, Wang N, Chen M, You X,
Zhao X, Solomides CC, Qin Y and Sun J: MicroRNA-663 regulates human
vascular smooth muscle cell phenotypic switch and vascular
neointimal formation. Circ Res. 113:1117–1127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stenvold H, Donnem T, Andersen S, Al-Saad
S, Busund LT and Bremnes RM: Stage and tissue-specific prognostic
impact of miR-182 in NSCLC. BMC Cancer. 14:1382014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mihelich BL, Khramtsova EA, Arva N,
Vaishnav A, Johnson DN, Giangreco AA, Martens-Uzunova E, Bagasra O,
Kajdacsy-Balla A and Nonn L: miR-183-96-182 cluster is
overexpressed in prostate tissue and regulates zinc homeostasis in
prostate cells. J Biol Chem. 286:44503–44511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu B, Qian T, Wang Y, Zhou S, Ding G, Ding
F and Gu X: miR-182 inhibits Schwann cell proliferation and
migration by targeting FGF9 and NTM, respectively at an early stage
following sciatic nerve injury. Nucleic Acids Res. 40:10356–10365.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Naruo K, Seko C, Kuroshima K, Matsutani E,
Sasada R, Kondo T and Kurokawa T: Novel secretory heparin-binding
factors from human glioma cells (glia-activating factors) involved
in glial cell growth. Purification and biological properties. J
Biol Chem. 268:2857–2864. 1993.PubMed/NCBI
|
|
15
|
Miyakawa K, Hatsuzawa K, Kurokawa T, Asada
M, Kuroiwa T and Imamura T: A hydrophobic region locating at the
center of fibroblast growth factor-9 is crucial for its secretion.
J Biol Chem. 274:29352–29357. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frontini MJ, Nong Z, Gros R, Drangova M,
O'Neil C, Rahman MN, Akawi O, Yin H, Ellis CG and Pickering JG:
Fibroblast growth factor 9 delivery during angiogenesis produces
durable, vasoresponsive microvessels wrapped by smooth muscle
cells. Nat Biotechnol. 29:421–427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Andrae J, Gallini R and Betsholtz C: Role
of platelet-derived growth factors in physiology and medicine.
Genes Dev. 22:1276–1312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hellström M, Kalén M, Lindahl P, Abramsson
A and Betsholtz C: Role of PDGF-B and PDGFR-beta in recruitment of
vascular smooth muscle cells and pericytes during embryonic blood
vessel formation in the mouse. Development. 126:3047–3055.
1999.PubMed/NCBI
|
|
19
|
Metz RP, Patterson JL and Wilson E:
Vascular smooth muscle cells: Isolation, culture, and
characterization. Methods Mol Biol. 843:169–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Wang Y, Du W, Liu W, Liu F, Zhang
L, Zhang M, Hou M, Liu K, Zhang S and Yu B: Wnt1 inhibits hydrogen
peroxide-induced apoptosis in mouse cardiac stem cells. PLoS One.
8:e588832013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang F, Zhong S, Zhang H, Zhang W, Zhang
H, Wu X and Chen B: Prognostic value of MicroRNA-182 in cancers: A
meta-analysis. Dis Markers. 2015:4821462015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang W, Qian P, Zhang X, Zhang M, Wang H,
Wu M, Kong X, Tan S, Ding K, Perry JK, et al: Autocrine/paracrine
human growth hormone-stimulated MicroRNA 96-182-183 cluster
promotes epithelial-mesenchymal transition and invasion in breast
cancer. J Biol Chem. 290:13812–13829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Zhang D, Wang X, Yao X, Ye C, Zhang
S, Wang H, Chang C, Xia H, Wang YC, et al: Hypoxia-inducible
miR-182 enhances HIF1α signaling via targeting HD2 and FIH1 in
prostate cancer. Sci Rep. 5:124952015. View Article : Google Scholar
|
|
24
|
Du C, Weng X, Hu W, Lv Z, Xiao H, Ding C,
Gyabaah OA, Xie H, Zhou L, Wu J and Zheng S: Hypoxia-inducible
miR-182 promotes angiogenesis by targeting RASA1 in hepatocellular
carcinoma. J Exp Clin Cancer Res. 34:672015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen L, Chu F, Cao Y, Shao J and Wang F:
Serum miR-182 and miR-3313p as diagnostic and prognostic markers in
patients with hepatocellular carcinoma. Tumour Biol. 36:7439–7447.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang L, Chen F, Pang EJ, Zhang ZQ, Jin BW
and Dong WF: MicroRNA-182 inhibits proliferation through targeting
oncogenic ANUBL1 in gastric cancer. Oncol Rep. 33:1707–1716.
2015.PubMed/NCBI
|
|
27
|
Sun Y, Fang R, Li C, Li L, Li F, Ye X and
Chen H: Hsa-miR-182 suppresses lung tumorigenesis through
downregulation of RGS17 expression in vitro. Biochem Biophys Res
Commun. 396:501–507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moskwa P, Buffa FM, Pan Y, Panchakshari R,
Gottipati P, Muschel RJ, Beech J, Kulshrestha R, Abdelmohsen K,
Weinstock DM, et al: miR-182-mediated downregulation of BRCA1
impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell.
41:210–220. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chamley-Campbell J, Campbell GR and Ross
R: The smooth muscle cell in culture. Physiol Rev. 59:1–61.
1979.PubMed/NCBI
|
|
30
|
Shanahan CM and Weissberg PL: Smooth
muscle cell heterogeneity: Patterns of gene expression in vascular
smooth muscle cells in vitro and in vivo. Arterioscler Thromb Vasc
Biol. 18:333–338. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kouri FM, Hurley LA, Daniel WL, Day ES,
Hua Y, Hao L, Peng CY, Merkel TJ, Queisser MA, Ritner C, et al:
miR-182 integrates apoptosis, growth, and differentiation programs
in glioblastoma. Genes Dev. 29:732–745. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cinaroglu A, Ozmen Y, Ozdemir A, Ozcan F,
Ergorul C, Cayirlioglu P, Hicks D and Bugra K: Expression and
possible function of fibroblast growth factor 9 (FGF9) and its
cognate receptors FGFR2 and FGFR3 in postnatal and adult retina. J
Neurosci Res. 79:329–339. 2005. View Article : Google Scholar
|
|
33
|
Heldin CH, Ostman A and Rönnstrand L:
Signal transduction via platelet-derived growth factor receptors.
Biochim Biophys Acta. 1378:F79–F113. 1998.PubMed/NCBI
|
|
34
|
Cospedal R, Abedi H and Zachary I:
Platelet-derived growth factor-BB (PDGF-BB) regulation of migration
and focal adhesion kinase phosphorylation in rabbit aortic vascular
smooth muscle cells: Roles of phosphatidylinositol 3-kinase and
mitogen-activated protein kinases. Cardiovasc Res. 41:708–721.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Song MC, Kim EC, Kim WJ and Kim TJ:
Meso-dihydroguaiaretic acid inhibits rat aortic vascular smooth
muscle cell proliferation by suppressing phosphorylation of
platelet-derived growth factor receptor beta. Eur J Pharmacol.
744:36–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Caglayan E, Vantler M, Leppänen O,
Gerhardt F, Mustafov L, Ten Freyhaus H, Kappert K, Odenthal M,
Zimmermann WH, Tallquist MD and Rosenkranz S: Disruption of
platelet-derived growth factor-dependent phosphatidylinositol
3-kinase and phospholipase Cγ1 activity abolishes vascular smooth
muscle cell proliferation and migration and attenuates neointima
formation in vivo. J Am Coll Cardiol. 57:2527–2538. 2011.
View Article : Google Scholar : PubMed/NCBI
|
